Baxter and Momenta Form Global Collaboration to Develop and Commercialise Biosimilars
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 1 (Table of Contents)
Published: 13 Jan-2012
DOI: 10.3833/pdr.v2012.i1.1668 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Deals for the development and commercialisation of biosimilars have risen in prominence of late with the latest such deal being a global collaboration between Baxter International and Momenta Pharmaceuticals that covers up to six follow-on biologics...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS